本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Seres Therapeutics, Inc.

14.40
+2.2518.52%
盘前14.400.00000.00%08:30 EDT
成交量:12.50万
成交额:171.35万
市值:1.26亿
市盈率:1.60
高:14.40
开:12.24
低:12.24
收:12.15
数据加载中...
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

重要事件披露

8-K - Current report
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/17

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/14

重要事件披露

8-K - Current report
2020/08/13

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/13

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

重要事件披露

8-K - Current report
2020/07/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/22

重要事件披露

8-K - Current report